Pathogenicity of missense mutations in SURF1 deficiency inducing the Leigh syndrome.: Importance in diagnosis

被引:2
|
作者
Dubot, A
Hervouet, E
Mandon, G
Zabot, MT
Godinot, C [1 ]
机构
[1] Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France
[2] Hop Debrousse, Unite Biotechnol Cellulaire, F-69005 Lyon, France
关键词
cytochrome c oxidase deficiency; mitochondria; Leigh syndrome diagnosis; SURF1;
D O I
10.1016/j.mito.2004.05.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Leigh syndrome with cytochrome oxidase (COX) deficiency has been associated with SURF1 mutations. For patient diagnosis, distinction between neutral polymorphisms and pathogenic missense SURF1 mutations in Leigh syndrome is essential. We show that several missense SURF1 mutations did not allow a stable protein to be expressed. Absence of immunologically reactive SURF1 is, therefore, helpful to demonstrate their pathogenicity. In addition, we show that out of two previously described missense mutations housed by the same allele, only one, the T737 C was pathogenic. Indeed, transfection of T737 C mutated SURF1 in SURF1-deficient cells did not restore normal SURF1 stability and COX activity. On the contrary, the G604 C-mutated SURF1 did it and, hence, is a neutral variant. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [31] MRI in Leigh syndrome with SURF1 gene mutation - Reply
    Rahman, S
    Chong, WK
    Leonard, JV
    Brown, RM
    Brown, GK
    ANNALS OF NEUROLOGY, 2002, 51 (01) : 139 - 139
  • [32] Functional alteration of cytochrome c oxidase by SURF1 mutations in Leigh syndrome at normoxia and hypoxia
    Houstek, J
    Pecina, P
    Capkova, M
    Gnaiger, E
    Dubot, A
    Vojtiskova, A
    Hansikova, H
    Houstkova, H
    Zeman, J
    Godinot, C
    Pronicka, E
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2004, 1657 : 39 - 39
  • [33] Expression and functional analysis of SURF1 in Leigh syndrome patients with cytochrome c oxidase deficiency
    Yao, JB
    Shoubridge, EA
    HUMAN MOLECULAR GENETICS, 1999, 8 (13) : 2541 - 2549
  • [34] Syndrome Leigh caused by mutations in the SURF1 gene: clinical and molecular-genetic characteristics
    Tsygankova, P. G.
    Mikhailova, S. V.
    Zakharova, E. Yu.
    Pichkur, N. A.
    Il'ina, E. S.
    Nikolaeva, E. A.
    Rudenskaya, G. E.
    Dadali, E. L.
    Kolpakchi, L. M.
    Fedoniuk, I. D.
    Matushchenko, G. N.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (01) : 25 - 32
  • [35] ATP synthesis is reduced in cultured fibroblasts derived from patients with SURF1 mutations and Leigh syndrome
    Shepherd, R. K.
    Checcarelli, N.
    Naini, A.
    De Vivo, D. C.
    DiMauro, S.
    Sue, C. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 273 - 274
  • [36] Decreased affinity for oxygen of cytochrome-c oxidase in Leigh syndrome caused by SURF1 mutations
    Pecina, P
    Gnaiger, E
    Zeman, J
    Pronicka, E
    Houstek, J
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (05): : C1384 - C1388
  • [37] MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations
    Farina, L
    Chiapparini, L
    Uziel, G
    Bugiani, M
    Zeviani, M
    Savoiardo, M
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2002, 23 (07) : 1095 - 1100
  • [38] Diagnostic difficulties with common SURF1 mutations in patients with cytochrome oxidase-deficient Leigh syndrome
    Head, RA
    Brown, RM
    Brown, GK
    JOURNAL OF INHERITED METABOLIC DISEASE, 2004, 27 (01) : 57 - 65
  • [39] A novel SURF1 mutation results in Leigh syndrome with peripheral neuropathy caused by cytochrome c oxidase deficiency
    Santoro, L
    Carrozzo, R
    Malandrini, A
    Piemonte, F
    Patrono, C
    Villanova, M
    Tessa, A
    Palmeri, S
    Bertini, E
    Santorelli, FM
    NEUROMUSCULAR DISORDERS, 2000, 10 (06) : 450 - 453
  • [40] Contrasting Cases in Neuropsychological Profiles of Leigh Syndrome With SURF1 Gene Mutation
    Cabrales, A.
    Magallanes, A.
    Wer, Macdonald B.
    Edgar, Bordes, V
    CLINICAL NEUROPSYCHOLOGIST, 2024, 38 (04) : 863 - 864